Optical coherence tomography and neurodegeneration: are eyes the windows to the brain?

References

• Wilson SW, Houart C. Early steps in the development of the forebrain. Dev Cell. 2004;6(2):167–181.
   PubMed Web of Science ®Google Scholar
• Wassle H. Parallel processing in the mammalian retina. Nat Rev Neurosci. 2004;5(10):747–757.
   PubMed Web of Science ®Google Scholar
• Athanasiou D, Aguilà M, Bevilacqua D, et al. The cell stress machinery and retinal degeneration. FEBS Lett. 2013;587(13):2008–2017.
   PubMed Web of Science ®Google Scholar
• Prasad S, Galetta SL. Anatomy and physiology of the afferent visual system. Handb Clin Neurol. 2011;102:3–19.
   PubMedGoogle Scholar
• Reynolds A, Laurie C, Lee Mosley R, et al. Oxidative stress and the pathogenesis of neurodegenerative disorders. In: Giacinto Bagetta MTC, Stuart AL, editors. International review of neurobiology. New York (NY): Academic Press; 2007. p. 297–325.
   Google Scholar
• You Y, Gupta VK, Graham SL, et al. Anterograde degeneration along the visual pathway after optic nerve injury. PLoS One. 2012;7(12):e52061.
   Google Scholar
• Buhl EH, Schwerdtfeger WK, Germroth P, et al. Combining retrograde tracing, intracellular injection, anterograde degeneration and electron microscopy to reveal synaptic links. J Neurosci Methods. 1989;29(3):241–250.
   PubMed Web of Science ®Google Scholar
• London A, Benhar I, Schwartz M. The retina as a window to the brain-from eye research to CNS disorders. Nat Rev Neurol. 2013;9(1):44–53.
   PubMed Web of Science ®Google Scholar
• Hee MR, Izatt JA, Swanson EA, et al. OPtical coherence tomography of the human retina. Arch Ophthalmol. 1995;113(3):325–332.
   PubMed Web of Science ®Google Scholar
• Huang D, Swanson E, Lin C, et al. Optical coherence tomography. Science. 1991;254(5035):1178–1181.
   PubMed Web of Science ®Google Scholar
• Mathur D, Cano AH. Preclinical retinal neurodegeneration in a model of multiple sclerosis: the journal of neuroscience 2012; 32(16):5585–5597. Ann Neurosci. 2012;19(3):121–122.
   PubMedGoogle Scholar
• Crish SD, Sappington RM, Inman DM, et al. Distal axonopathy with structural persistence in glaucomatous neurodegeneration. Proc Natl Acad Sci U S A. 2010;107(11):5196–5201.
   PubMed Web of Science ®Google Scholar
• Lu Y, Li Z, Zhang X, et al. Retinal nerve fiber layer structure abnormalities in early Alzheimer’s disease: evidence in optical coherence tomography. Neurosci Lett. 2010;480(1):69–72.
   PubMed Web of Science ®Google Scholar
• Petzold A, De Boer JF, Schippling S, et al. Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol. 2010;9(9):921–932.
   PubMed Web of Science ®Google Scholar
• Aaker GD, Myung JS, Ehrlich JR, et al. Detection of retinal changes in Parkinson’s disease with spectral-domain optical coherence tomography. Clinical Ophthalmol. 2010;4:1427.
   PubMedGoogle Scholar
• Schmitt JM. Optical coherence tomography (OCT): a review. IEEE J Select Top Quantum Electron. 1999;5(4):1205–1215.
   Web of Science ®Google Scholar
• De Boer JF, Cense B, Park BH, et al. Improved signal-to-noise ratio in spectral-domain compared with time-domain optical coherence tomography. Opt Lett. 2003;28(21):2067–2069.
   PubMed Web of Science ®Google Scholar
• Choma M, Sarunic M, Yang C, et al. Sensitivity advantage of swept source and Fourier domain optical coherence tomography. Opt Express. 2003;11(18):2183–2189.
   PubMed Web of Science ®Google Scholar
• Sarunic M, Choma MA, Yang C, et al. Instantaneous complex conjugate resolved spectral domain and swept-source OCT using 3x3 fiber couplers. Optics Express. 2005;13(3):957–967.
   PubMed Web of Science ®Google Scholar
• Podoleanu AG. Optical coherence tomography. Br J Radiol. 2005;78(935):976–988.
   PubMed Web of Science ®Google Scholar
• Jafri MS, Farhang S, Tang RS, et al. Optical coherence tomography in the diagnosis and treatment of neurological disorders. J Biomed Opt. 2005;10(5):051603-051603-051611.
   PubMed Web of Science ®Google Scholar
• Frohman EM, Fujimoto JG, Frohman TC, et al. Optical coherence tomography: a window into the mechanisms of multiple sclerosis. Nat Clin Pract Neurol. 2008;4(12):664–675.
   PubMedGoogle Scholar
• Cowan W. Anterograde and retrograde transneuronal degeneration in the central and peripheral nervous system. In: Nauta WJH, Ebbesson SOE, editors. Contemporary research methods in neuroanatomy. Berlin: Springer; 1970. p. 217–251.
   Google Scholar
• Calabresi PA, Balcer LJ, Frohman EM, editors. Optical coherence tomography in neurological diseases. Cambridge: Cambridge University Press; 2015
   Google Scholar
• Lublin FD, Reingold SC, Cohen JA, et al. Defining the clinical course of multiple sclerosis the 2013 revisions. Neurology. 2014;83(3):278–286.
   PubMed Web of Science ®Google Scholar
• Kale N. Management of optic neuritis as a clinically first event of multiple sclerosis. Curr Opin Ophthalmol. 2012;23(6):472–476.
   PubMed Web of Science ®Google Scholar
• Filippi M, Rocca MA, Barkhof F, et al. Association between pathological and MRI findings in multiple sclerosis. Lancet Neurol. 2012;11(4):349–360.
   PubMed Web of Science ®Google Scholar
• Jacobs LD, Beck RW, Simon JH, et al. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS study group. N Engl J Med. 2000;343(13):898–904.
   PubMed Web of Science ®Google Scholar
• Comi G, Martinelli V, Rodegher M, et al. Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome. Mult Scler. 2013;19(8):1074–1083.
   PubMed Web of Science ®Google Scholar
• Walter SD, Ishikawa H, Galetta KM, et al. Ganglion cell loss in relation to visual disability in multiple sclerosis. Ophthalmology. 2012;119(6):1250–1257.
   PubMed Web of Science ®Google Scholar
• Frisen L, Hoyt WF. Insidious atrophy of retinal nerve fibers in multiple sclerosis: funduscopic identification in patients with and without visual complaints. Arch Ophthalmol. 1974;92(2):91–97.
   PubMedGoogle Scholar
• Kerrison JB, Flynn T, Green WR. Retinal pathologic changes in multiple sclerosis. Retina. 1994;14(5):445–451.
   PubMed Web of Science ®Google Scholar
• Sadun AA, Wang MY. Abnormalities of the optic disc. Handb Clin Neurol. 2011;102:117–157.
   PubMedGoogle Scholar
• Parisi V, Manni G, Spadaro M, et al. Correlation between morphological and functional retinal impairment in multiple sclerosis patients. Invest Ophthalmol Vis Sci. 1999;40:2520–2527.
   PubMed Web of Science ®Google Scholar
• Trip SA, Schlottmann PG, Jones SJ, et al. Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Ann Neurol. 2005;58(3):383–391.
   PubMed Web of Science ®Google Scholar
• Al-Louzi OA, Bhargava P, Newsome SD, et al. Outer retinal changes following acute optic neuritis. Mult Scler. 2016;22(3):362–372.
   PubMed Web of Science ®Google Scholar
• Okuda DT, Mowry EM, Beheshtian A, et al. Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome. Neurology. 2009;72(9):800–805.
   PubMed Web of Science ®Google Scholar
• Knier B, Berthele A, Buck D, et al. Optical coherence tomography indicates disease activity prior to clinical onset of central nervous system demyelination. Mult Scler. 2015. [Epub ahead of print]
   Google Scholar
• Saidha S, Syc SB, Ibrahim MA, et al. Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain. 2011;134(Pt 2):518–533.
   PubMed Web of Science ®Google Scholar
• Saidha S, Syc SB, Durbin MK, et al. Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness. Mult Scler. 2011;17(12):1449–1463.
   PubMed Web of Science ®Google Scholar
• Grazioli E, Zivadinov R, Weinstock-Guttman B, et al. Retinal nerve fiber layer thickness is associated with brain MRI outcomes in multiple sclerosis. J Neurol Sci. 2008;268(1–2):12–17.
   PubMed Web of Science ®Google Scholar
• Scheel M, Finke C, Oberwahrenbrock T, et al. Retinal nerve fibre layer thickness correlates with brain white matter damage in multiple sclerosis: a combined optical coherence tomography and diffusion tensor imaging study. Mult Scler. 1904-1907;20(14):2014.
   Google Scholar
• Oberwahrenbrock T, Schippling S, Ringelstein M, et al. Retinal damage in multiple sclerosis disease subtypes measured by high-resolution optical coherence tomography. Mult Scler Int. 2012;2012:530305.
   PubMedGoogle Scholar
• Talman LS, Bisker ER, Sackel DJ, et al. Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis. Ann Neurol. 2010;67(6):749–760.
   PubMed Web of Science ®Google Scholar
• Saidha S, Al-Louzi O, Ratchford JN, et al. Optical coherence tomography reflects brain atrophy in multiple sclerosis: A four-year study. Ann Neurol. 2015;78(5):801–813.
   PubMed Web of Science ®Google Scholar
• Martinez-Lapiscina EH, Arnow S, Wilson JA, et al. Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study. Lancet Neurol. 2016;15(6):574–584.
   PubMed Web of Science ®Google Scholar
• Schippling S, Balk LJ, Costello F, et al. Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria. Mult Scler. 2015;21(2):163–170.
   PubMed Web of Science ®Google Scholar
• Saidha S, Sotirchos ES, Oh J, et al. Retinal axonal and neuronal measures in multiple sclerosis reflect global CNS pathology. JAMA Neurol. 2013;70(1):34–43.
   PubMed Web of Science ®Google Scholar
• Talla V, Yu H, Chou TH, et al. NADH-dehydrogenase type-2 suppresses irreversible visual loss and neurodegeneration in the EAE animal model of MS. Mol Ther. 2013;21(10):1876–1888.
   PubMed Web of Science ®Google Scholar
• Talla V, Koilkonda R, Porciatti V, et al. Complex I subunit gene therapy with NDUFA6 ameliorates neurodegeneration in EAE. Invest Ophthalmol Vis Sci. 2015;56(2):1129–1140.
   PubMed Web of Science ®Google Scholar
• Li Q, Timmers AM, Hunter K, et al. Noninvasive imaging by optical coherence tomography to monitor retinal degeneration in the mouse. Invest Ophthalmol Vis Sci. 2001;42(12):2981–2989.
   PubMed Web of Science ®Google Scholar
• McLellan GJ, Rasmussen CA. Optical coherence tomography for the evaluation of retinal and optic nerve morphology in animal subjects: practical considerations. Vet Ophthalmol. 2012;15(Suppl 2):13–28.
   PubMed Web of Science ®Google Scholar
• Frohman E, Costello F, Zivadinov R, et al. Optical coherence tomography in multiple sclerosis. Lancet Neurol. 2006;5(10):853–863.
   PubMed Web of Science ®Google Scholar
• Mustafa S, Pandit L. Approach to diagnosis and management of optic neuropathy. Neurol India. 2014;62(6):599–605.
   PubMed Web of Science ®Google Scholar
• Galetta KM, Calabresi PA, Frohman EM, et al. Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration. Neurother: J Am Soc Exp Neurother. 2011;8(1):117–132.
   Web of Science ®Google Scholar
• Jarius S, Wildemann B, Paul F. Neuromyelitis optica: clinical features, immunopathogenesis and treatment. Clin Exp Immunol. 2014;176(2):149–164.
   PubMed Web of Science ®Google Scholar
• Wingerchuk DM, Banwell B, Bennett JL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85(2):177–189.
   PubMed Web of Science ®Google Scholar
• De Seze J, Blanc F, Jeanjean L, et al. OPtical coherence tomography in neuromyelitis optica. Arch Neurol. 2008;65(7):920–923.
   PubMedGoogle Scholar
• Ratchford JN, Quigg ME, Conger A, et al. Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies. Neurology. 2009;73(4):302–308.
   PubMed Web of Science ®Google Scholar
• Lange AP, Sadjadi R, Zhu F, et al. Spectral-domain optical coherence tomography of retinal nerve fiber layer thickness in NMO patients. J Neuroophthalmol. 2013;33(3):213–219.
   PubMed Web of Science ®Google Scholar
• Van Stavern GP. Metabolic, hereditary, traumatic, and neoplastic optic neuropathies. Continuum. 2014;20(4 Neuro–ophthalmology):877–906.
   PubMedGoogle Scholar
• Danesh-Meyer HV, Yap J, Frampton C, et al. Differentiation of compressive from glaucomatous optic neuropathy with spectral-domain optical coherence tomography. Ophthalmology. 2014;121(8):1516–1523.
   PubMed Web of Science ®Google Scholar
• Danesh-Meyer HV, Wong A, Papchenko T, et al. Optical coherence tomography predicts visual outcome for pituitary tumors. J Clin Neurosci. 2015;22(7):1098–1104.
   PubMed Web of Science ®Google Scholar
• Lenka A, Hegde S, Jhunjhunwala KR, et al. Interactions of visual hallucinations, rapid eye movement sleep behavior disorder and cognitive impairment in Parkinson’s disease: A review. Parkinsonism Relat Disord. 2016;22:1–8.
   PubMed Web of Science ®Google Scholar
• Hajee ME, March WF, Lazzaro DR, et al. Inner retinal layer thinning in Parkinson disease. Arch Ophthalmol. 2009;127(6):737–741.
   PubMedGoogle Scholar
• Jimenez B, Ascaso FJ, Cristobal JA. Lopez del Val J. Development of a prediction formula of Parkinson disease severity by optical coherence tomography. Move Disord: Off J Move Disord Soc. 2014;29(1):68–74.
   PubMed Web of Science ®Google Scholar
• Garcia-Martin E, Rodriguez-Mena D, Satue M, et al. Electrophysiology and optical coherence tomography to evaluate Parkinson disease severity. Invest Opthalmol Vis Sci. 2014;55(2):696–705.
   PubMed Web of Science ®Google Scholar
• Iseri PK, Altinas O, Tokay T, et al. Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. J Neuro-Ophthalmol. 2006;26(1):18–24.
   PubMed Web of Science ®Google Scholar
• Cheung CY, Ong YT, Hilal S, et al. Retinal ganglion cell analysis using high-definition optical coherence tomography in patients with mild cognitive impairment and Alzheimer’s disease. J Alzheimer’s Dis: JAD. 2015;45(1):45–56.
   PubMed Web of Science ®Google Scholar
• Wang D, Li Y, Wang C, et al. Localized retinal nerve fiber layer defects and stroke. Stroke. 1651-1656;45(6):2014.
   Google Scholar
• Park HY, Park YG, Cho AH, et al. Transneuronal retrograde degeneration of the retinal ganglion cells in patients with cerebral infarction. Ophthalmology. 2013;120(6):1292–1299.
   PubMed Web of Science ®Google Scholar
• Liu G, Chen Z. Advances in Doppler OCT. Chinese Opt Lett: COL. 2013;11(1):011702.
   Google Scholar
• Yu L, Nguyen E, Liu G, et al. Spectral Doppler optical coherence tomography imaging of localized ischemic stroke in a mouse model. J Biomed Opt. 2010;15(6):066006.
   Google Scholar
• Srinivasan VJ, Mandeville ET, Can A, et al. Multiparametric, longitudinal optical coherence tomography imaging reveals acute injury and chronic recovery in experimental ischemic stroke. PLoS One. 2013;8(8):e71478.
   Google Scholar
• Butler PD, Javitt DC. Early-stage visual processing deficits in schizophrenia. Curr Opin Psychiatry. 2005;18(2):151–157.
   PubMed Web of Science ®Google Scholar
• Lavoie J, Illiano P, Sotnikova TD, et al. The electroretinogram as a biomarker of central dopamine and serotonin: potential relevance to psychiatric disorders. Biol Psychiatry. 2014;75(6):479–486.
   PubMed Web of Science ®Google Scholar
• Ascaso FJ, Rodriguez-Jimenez R, Cabezón L, et al. Retinal nerve fiber layer and macular thickness in patients with schizophrenia: influence of recent illness episodes. Psychiatr Res. 2015;229(1–2):230–236.
   PubMed Web of Science ®Google Scholar
• Chu EM, Kolappan M, Barnes TR, et al. A window into the brain: an in vivo study of the retina in schizophrenia using optical coherence tomography. Psychiatry Res. 2012;203(1):89–94.
   PubMed Web of Science ®Google Scholar
• Lee WW, Tajunisah I, Sharmilla K, et al. Retinal nerve fiber layer structure abnormalities in schizophrenia and its relationship to disease state: evidence from optical coherence tomography. Invest Opthalmol Vis Sci. 2013;54(12):7785–7792.
   PubMed Web of Science ®Google Scholar
• Bezerra HG, Costa MA, Guagliumi G, et al. Intracoronary optical coherence tomography: a comprehensive reviewclinical and research applications. JACC: Cardiovasc Interv. 2009;2(11):1035–1046.
   PubMed Web of Science ®Google Scholar